Description:
HYPERLIPOPROTEINEMIA, TYPE I
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Lipid Metabolism |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
2 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| lipoprotein lipase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.1.1.34 |
| |
| Remarks |
Cutaneous xanthomas; hypertriglyceridemia; similarly affected brother; lipoprotein lipase deficiency; no apolipoprotein C-II deficiency; normal cholesterol level; concentration of low & high density lipoproteins is depressed |
| Gene Ontology |
GO:0004465 lipoprotein lipase activity |
|
GO:0005319 lipid transporter activity |
|
GO:0005576 extracellular |
|
GO:0006631 fatty acid metabolism |
|
GO:0008015 circulation |
|
GO:0008201 heparin binding |
|
GO:0016042 lipid catabolism |
|
GO:0016787 hydrolase activity |
| NCBI Gene |
Gene ID:4023 |
| NCBI GTR |
238600 HYPERLIPOPROTEINEMIA, TYPE I |
| OMIM |
238600 HYPERLIPOPROTEINEMIA, TYPE I |
| Omim Description |
CHYLOMICRONEMIA, FAMILIALLIPOPROTEIN LIPASE, INCLUDED; LPL, INCLUDED |
| |
HYPERCHYLOMICRONEMIA, FAMILIAL |
| |
HYPERLIPEMIA, ESSENTIAL FAMILIAL |
| |
HYPERLIPEMIA, IDIOPATHIC, BURGER-GRUTZ TYPE |
| |
HYPERLIPOPROTEINEMIA, TYPE I |
| |
HYPERLIPOPROTEINEMIA, TYPE IA |
| |
LIPASE D DEFICIENCY |
| |
LIPD DEFICIENCY |
| |
LIPOPROTEIN LIPASE DEFICIENCY |
| |
LPL DEFICIENCY |
| Passage Frozen |
2 |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|